Prevalence of hyperandrogenic states in late adolescent and young women: Epidemiological survey on Italian high-school students

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages 1641-1650

  Gambineri, Alessandra ^a   Fanelli, Flaminia ^a   Prontera, Olga ^a   Repaci, Andrea ^a   Di Dalmazi, Guido ^a   Zanotti, Laura ^a   Pagotto, Uberto ^a   Flacco, Maria Elena ^c   Guidi, Jenny ^b   Fava, Giovanni Andrea ^b   Manzoli, Lamberto ^c   Pasquali, Renato ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ADOLESCENT; ADULT; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HIGH SCHOOL; HIGH SCHOOL STUDENT; HIRSUTISM; HUMAN; HUMAN CELL; HYPERANDROGENISM; INDEPENDENT VARIABLE; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MENSTRUAL IRREGULARITY; OVARY POLYCYSTIC DISEASE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; AGE OF ONSET; ALGORITHMS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; HYPERANDROGENISM; ITALY; PREVALENCE; PROGNOSIS; SCHOOLS; STUDENTS; YOUNG ADULT;

EID: 84876222439     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3537     Document Type: Review

References (39)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999; 84: 4006-4011.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89: 2745-2749.
3. Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008; 139: 59-64.
4. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010; 25: 544-551.
5. Moran C, Tena G, Moran S, Ruiz P, Reyna R, Duque X. Prevalence of polycystic ovary syndrome and related disorders in Mexican women. Gynecol Obstet Invest. 2010; 69: 274-280.
6. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011; 9: 39-46.
7. Sanchoacgrn R, Gambineri A, Alpañés M, Martiacgrnez - Garciacgra MÁ, Pasquali R, Escobarr-Morreale HF. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod. 2012; 27: 1209-1216.
8. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011; 24: 223-227.
9. Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ, Hart R. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod. 2011; 26: 1469-1477.
10. Apter D, Vihko R. Premenarcheal endocrine changes in relation to age at menarche. Clin Endocrinol (Oxf). 1985; 22: 753-760.
11. Rosenfield RL, Ghai K, Ehrmann DA, Barnes RB. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab 2000; 13: 1285-1289.
12. Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol. 2011; 4: 45-51.
13. Talluri T, Lietdke RJ, Evangelisti A, Talluri J, Maggia G. Fat-free mass qualitative assessment with bioelectric impedance analysis (BIA). Ann NY Acad Sci. 1999; 873: 94-98.
14. Piccoli A, Nigrelli S, Caberlotto A, et al. Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations. Am J Clin Nutr. 1995; 61: 269-270.
15. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140: 815-830.
16. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977; 97: 247-254.
17. Burke BM, Cunliffe WJ. The assessment of acne vulgaris-the Leeds technique. Br J Dermatol. 1984; 111: 83-92.
18. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care. 1999; 22: 1655-1659.
19. Fanelli F, Belluomo I, Di Lallo VD, et al. Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids. 2011; 76: 244-253.
20. Fanelli F, Belluomo I, Di Lallo V, et al. Androgen profiling in adolescent females by liquid chromatography-tandem mass spectrometry. Proc 15th International and 14th European Congress of Endocrinology, May 5-9, 2012, Florence, Italy.
21. Matthews DR, Hosker IP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.
22. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: implication for research application. J Clin Endocrinol Metab. 2001; 86: 5457-5464.
23. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999; 84: 3666-3672.
24. Goodman A. Terminology and evaluation of abnormal uterine bleeding in premenopausal women. In: Rose BD, ed. UpToDate. Waltham, MA: Up To Date, Inc; 2007.
25. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992.
26. Manzoli L, Di Giovanni P, Del Duca L, et al. Use of hormone replacement therapy in Italian women aged 50-70 years. Maturitas. 2004; 49: 241-251.
27. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd ed. New York: John Wiley, Sons; 2000.
28. Hamilton LC. Statistics with Stata (updated for version 9). Belmont, CA: Thomson-Brooks/Cole; 2006.
29. Wild RA, Vesely S, Beebe L, Whitsett T, Owen W. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90: 4112-4114.
30. Janse F, Eijkemans MJC, Goverde AJ, et al. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol. 2011; 165: 925-933.
31. Barth JH, Field HP, Yasmin E, Balen AH. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots. Eur J Endocrinol. 2010; 162: 611-615.
32. Legro RS, Schlaff WD, Diamond MP, et al, and for the Reproductive Medicine Network. 2010 Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab 95: 5305-5313.
33. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal CK, Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod 2004; 19: 383-392.
34. Nair MKC, Pappachan P, Balakrishnan S, Leena ML, George B, Russell PS. Menstrual irregularity and polycystic ovarian syndrome among adolescent girls-a 2 year follow-up study. Indian J Pediatr 2012; 79: S69-S73.
35. Barbato MT, da Silva AK, Guerine MB, Criado PR, Averbeck E, de Sá NB. Association of acanthos is nigricans and skin tagswith insulin resistance. Ann Bras Dermatol. 2012; 87: 97-104.
36. Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol 2007; 57: 502-508.
37. Pasquali R, Antenucci D, Casimirri F, et al. Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries. J Endocrinol Invest. 1987; 10: 575-579.
38. Lindgren F, Dahlquist G, Efendic S, Persson B, Skottner A. Insulin sensitivity and glucose-induced insulin response changes during adolescence. Acta Paediatr Scand 1990; 79: 431-436.
39. Laitinen J, Taponen S, Martikainen H, et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int J Obes Relat Metab Disord. 2003; 27: 710-715.